ENLV (Enlivex) Notes Receivable: $0.00 Mil (As of Dec. 2025)


ENLV Enlivex Ltd ENLV
31 GF Score
Price $7.26
! 2 Warning Signs
View Full Analysis

What is Enlivex Notes Receivable?

Enlivex ENLV -1.94% 31 Notes Receivable is $0.00 Mil as of Dec. 2025. GuruFocus rates ENLV with a GF Score™ of 31/100. The stock has 2 warning signs investors should review.

Enlivex's Notes Receivable for the quarter that ended in Dec. 2025 was $0.00 Mil.


Enlivex Notes Receivable Historical Data

* Premium members only.

The historical data trend for Enlivex's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enlivex Notes Receivable Chart

Enlivex Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Enlivex Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ENLV
31GF Score
Enlivex Ltd ENLV
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Enlivex Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Enlivex (ENLV) has a Notes Receivable of $0.00 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Enlivex and its competitors.
Is Enlivex's Notes Receivable too high?
Enlivex's current Notes Receivable is $0.00 Mil. Overall, Enlivex has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Enlivex's Notes Receivable compare to CNTB and SMNR?
Enlivex's Notes Receivable of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Biotechnology company?
A good Notes Receivable depends on the Biotechnology industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Enlivex and its competitors. Enlivex's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Enlivex stock overvalued right now?
Enlivex (ENLV) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Enlivex's overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Enlivex (ENLV), the current Notes Receivable is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Enlivex Business Description

Other Exchanges 1BT:Germany
Address 14 Einstein Street, Weizmann Science Park, Ness Ziona, ISR, 7403618
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.
31GF Score

Get the complete analysis for ENLV

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.26
Price